These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

518 related articles for article (PubMed ID: 27246801)

  • 1. High morbidity and mortality of Clostridium difficile infection and its associations with ribotype 002 in Hong Kong.
    Wong SH; Ip M; Hawkey PM; Lo N; Hardy K; Manzoor S; Hui WW; Choi KW; Wong RY; Yung IM; Cheung CS; Lam KL; Kwong T; Wu WK; Ng SC; Wu JC; Sung JJ; Lee N
    J Infect; 2016 Aug; 73(2):115-22. PubMed ID: 27246801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hospital-based Clostridium difficile infection surveillance reveals high proportions of PCR ribotypes 027 and 176 in different areas of Poland, 2011 to 2013.
    Pituch H; Obuch-Woszczatyński P; Lachowicz D; Wultańska D; Karpiński P; Młynarczyk G; van Dorp SM; Kuijper EJ;
    Euro Surveill; 2015; 20(38):. PubMed ID: 26536049
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Occurrence of Clostridium difficile PCR-ribotype 027 and it's closely related PCR-ribotype 176 in hospitals in Poland in 2008-2010.
    Obuch-Woszczatyński P; Lachowicz D; Schneider A; Mól A; Pawłowska J; Ożdżeńska-Milke E; Pruszczyk P; Wultańska D; Młynarczyk G; Harmanus C; Kuijper EJ; van Belkum A; Pituch H
    Anaerobe; 2014 Aug; 28():13-7. PubMed ID: 24799338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of healthcare exposure with acquisition of different Clostridium difficile strain types in patients with recurrent infection or colonization after clinical resolution of initial infection.
    Thabit AK; Housman ST; Burnham CD; Nicolau DP
    J Hosp Infect; 2016 Feb; 92(2):167-72. PubMed ID: 26792686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced surveillance of Clostridium difficile infection occurring outside hospital, England, 2011 to 2013.
    Fawley WN; Davies KA; Morris T; Parnell P; Howe R; Wilcox MH;
    Euro Surveill; 2016 Jul; 21(29):. PubMed ID: 27487436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical features and characteristics of Clostridium difficile PCR-ribotype 176 infection: results from a 1-year university hospital internal ward study.
    Drabek J; Nyc O; Krutova M; Stovicek J; Matejkova J; Keil R
    Ann Clin Microbiol Antimicrob; 2015 Dec; 14():55. PubMed ID: 26698842
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A prospective study of community-associated Clostridium difficile infections: the role of antibiotics and co-infections.
    Taori SK; Wroe A; Hardie A; Gibb AP; Poxton IR
    J Infect; 2014 Aug; 69(2):134-44. PubMed ID: 24780765
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In the Endemic Setting, Clostridium difficile Ribotype 027 Is Virulent But Not Hypervirulent.
    Aitken SL; Alam MJ; Khaleduzzaman M; Walk ST; Musick WL; Pham VP; Christensen JL; Atmar RL; Xie Y; Garey KW
    Infect Control Hosp Epidemiol; 2015 Nov; 36(11):1318-23. PubMed ID: 26288985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increasing prevalence of the epidemic ribotype 106 in healthcare facility-associated and community-associated Clostridioides difficile infection.
    Suárez-Bode L; Barrón R; Pérez JL; Mena A
    Anaerobe; 2019 Feb; 55():124-129. PubMed ID: 30550807
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diversity of Clostridium difficile PCR ribotypes in Europe: results from the European, multicentre, prospective, biannual, point-prevalence study of Clostridium difficile infection in hospitalised patients with diarrhoea (EUCLID), 2012 and 2013.
    Davies KA; Ashwin H; Longshaw CM; Burns DA; Davis GL; Wilcox MH;
    Euro Surveill; 2016 Jul; 21(29):. PubMed ID: 27470194
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An Outbreak of Clostridium difficile Ribotype 027 Associated with Length of Stay in the Intensive Care Unit and Use of Selective Decontamination of the Digestive Tract: A Case Control Study.
    van Beurden YH; Dekkers OM; Bomers MK; Kaiser AM; van Houdt R; Knetsch CW; Girbes AR; Mulder CJ; Vandenbroucke-Grauls CM
    PLoS One; 2016; 11(8):e0160778. PubMed ID: 27533048
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence of Clostridium difficile infection in patients receiving high-risk antibiotics with or without a proton pump inhibitor.
    Gordon D; Young LR; Reddy S; Bergman C; Young JD
    J Hosp Infect; 2016 Feb; 92(2):173-7. PubMed ID: 26616410
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clostridium difficile ribotype 176 - A predictor for high mortality and risk of nosocomial spread?
    Polivkova S; Krutova M; Petrlova K; Benes J; Nyc O
    Anaerobe; 2016 Aug; 40():35-40. PubMed ID: 27155489
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changing epidemiology of Clostridium difficile infection following the introduction of a national ribotyping-based surveillance scheme in England.
    Wilcox MH; Shetty N; Fawley WN; Shemko M; Coen P; Birtles A; Cairns M; Curran MD; Dodgson KJ; Green SM; Hardy KJ; Hawkey PM; Magee JG; Sails AD; Wren MW
    Clin Infect Dis; 2012 Oct; 55(8):1056-63. PubMed ID: 22784871
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Type-specific risk factors and outcome in an outbreak with 2 different Clostridium difficile types simultaneously in 1 hospital.
    Goorhuis A; Debast SB; Dutilh JC; van Kinschot CM; Harmanus C; Cannegieter SC; Hagen EC; Kuijper EJ
    Clin Infect Dis; 2011 Nov; 53(9):860-9. PubMed ID: 21914851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Host factors are more important in predicting recurrent Clostridium difficile infection than ribotype and use of antibiotics.
    van Beurden YH; Nezami S; Mulder CJJ; Vandenbroucke-Grauls CMJE
    Clin Microbiol Infect; 2018 Jan; 24(1):85.e1-85.e4. PubMed ID: 28782647
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The emergence of Clostridium difficile ribotypes 027 and 176 with a predominance of the Clostridium difficile ribotype 001 recognized in Slovakia following the European standardized Clostridium difficile infection surveillance of 2016.
    Novakova E; Stefkovicova M; Kopilec MG; Novak M; Kotlebova N; Kuijper E; Krutova M
    Int J Infect Dis; 2020 Jan; 90():111-115. PubMed ID: 31707136
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The emergence of Clostridium difficile PCR-ribotype 001 in Slovakia.
    Nyc O; Krutova M; Liskova A; Matejkova J; Drabek J; Kuijper EJ
    Eur J Clin Microbiol Infect Dis; 2015 Aug; 34(8):1701-8. PubMed ID: 25981433
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular characteristics of Clostridium difficile strains from patients with a first recurrence more than 8 weeks after the primary infection.
    Chen Y; Rashid MU; Huang H; Fang H; Nord CE; Wang M; Weintraub A
    J Microbiol Immunol Infect; 2017 Aug; 50(4):532-536. PubMed ID: 26698688
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Community-acquired Clostridium difficile: epidemiology, ribotype, risk factors, hospital and intensive care unit outcomes, and current and emerging therapies.
    Ofori E; Ramai D; Dhawan M; Mustafa F; Gasperino J; Reddy M
    J Hosp Infect; 2018 Aug; 99(4):436-442. PubMed ID: 29410012
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.